Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neuromuscular Blockade | 2 | 2019 | 66 | 1.56 | Why? |
| Neuromuscular Blocking Agents | 3 | 2020 | 121 | 1.10 | Why? |
| Haloperidol | 1 | 2018 | 78 | 0.69 | Why? |
| Conscious Sedation | 1 | 2019 | 222 | 0.67 | Why? |
| Antipsychotic Agents | 2 | 2018 | 887 | 0.47 | Why? |
| Electroencephalography | 1 | 2019 | 1242 | 0.47 | Why? |
| Pain | 1 | 2019 | 1084 | 0.44 | Why? |
| Delirium | 2 | 2018 | 1061 | 0.43 | Why? |
| Critical Illness | 8 | 2021 | 17281 | 0.41 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 5002 | 0.38 | Why? |
| Hypoxia | 3 | 2018 | 3626 | 0.36 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.31 | Why? |
| Lung Transplantation | 1 | 2017 | 1554 | 0.30 | Why? |
| Intensive Care Units | 12 | 2021 | 29594 | 0.30 | Why? |
| Critical Care | 4 | 2021 | 14081 | 0.23 | Why? |
| Idiopathic Pulmonary Fibrosis | 2 | 2019 | 595 | 0.23 | Why? |
| Respiration, Artificial | 7 | 2021 | 22116 | 0.20 | Why? |
| Acute Kidney Injury | 1 | 2019 | 5762 | 0.19 | Why? |
| Heparin | 2 | 2021 | 2600 | 0.18 | Why? |
| Ribs | 1 | 2017 | 8 | 0.18 | Why? |
| Axillary Vein | 1 | 2017 | 10 | 0.17 | Why? |
| Acetaminophen | 1 | 2020 | 326 | 0.17 | Why? |
| Vasopressins | 1 | 2018 | 70 | 0.17 | Why? |
| Subclavian Vein | 1 | 2017 | 32 | 0.17 | Why? |
| Norepinephrine | 1 | 2018 | 152 | 0.17 | Why? |
| Liver Failure, Acute | 1 | 2020 | 279 | 0.16 | Why? |
| Surge Capacity | 2 | 2021 | 894 | 0.16 | Why? |
| Radiation Exposure | 1 | 2018 | 161 | 0.15 | Why? |
| Cannula | 1 | 2021 | 750 | 0.15 | Why? |
| Organ Dysfunction Scores | 2 | 2019 | 1475 | 0.14 | Why? |
| Hypnotics and Sedatives | 1 | 2020 | 624 | 0.14 | Why? |
| Sepsis | 4 | 2019 | 3517 | 0.14 | Why? |
| Hypotension | 1 | 2018 | 392 | 0.14 | Why? |
| Vasoconstrictor Agents | 1 | 2018 | 714 | 0.13 | Why? |
| Pulmonary Medicine | 1 | 2020 | 706 | 0.13 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.13 | Why? |
| Drug Overdose | 1 | 2020 | 583 | 0.13 | Why? |
| Ascorbic Acid | 1 | 2019 | 676 | 0.13 | Why? |
| Advisory Committees | 1 | 2020 | 1418 | 0.12 | Why? |
| Catheter-Related Infections | 1 | 2017 | 381 | 0.12 | Why? |
| Creatinine | 1 | 2019 | 1443 | 0.12 | Why? |
| Cognition Disorders | 1 | 2018 | 574 | 0.12 | Why? |
| APACHE | 3 | 2020 | 682 | 0.12 | Why? |
| Catheterization, Central Venous | 1 | 2017 | 458 | 0.12 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.12 | Why? |
| Analgesics, Opioid | 1 | 2020 | 1070 | 0.10 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 800 | 0.10 | Why? |
| Vitamins | 1 | 2019 | 1208 | 0.10 | Why? |
| Heart Arrest | 1 | 2021 | 1239 | 0.10 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.10 | Why? |
| Humans | 32 | 2021 | 930598 | 0.10 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.09 | Why? |
| Multiple Organ Failure | 1 | 2019 | 1724 | 0.09 | Why? |
| Ventilators, Mechanical | 1 | 2021 | 2193 | 0.09 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.09 | Why? |
| Respiratory Insufficiency | 2 | 2020 | 7301 | 0.09 | Why? |
| Length of Stay | 3 | 2020 | 11042 | 0.08 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2021 | 1876 | 0.08 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.08 | Why? |
| Societies, Medical | 2 | 2020 | 6907 | 0.08 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.08 | Why? |
| Prone Position | 1 | 2018 | 1861 | 0.08 | Why? |
| Dyspnea | 1 | 2019 | 3847 | 0.08 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Treatment Failure | 2 | 2021 | 2106 | 0.07 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.07 | Why? |
| Liver Transplantation | 1 | 2020 | 2864 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Adult | 11 | 2021 | 244371 | 0.07 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.07 | Why? |
| Ultrasonography | 1 | 2020 | 4409 | 0.07 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Retrospective Studies | 6 | 2019 | 105322 | 0.06 | Why? |
| Attitude of Health Personnel | 1 | 2021 | 4741 | 0.06 | Why? |
| Renal Dialysis | 1 | 2019 | 4358 | 0.06 | Why? |
| Female | 14 | 2021 | 380317 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Physicians | 1 | 2021 | 4214 | 0.06 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.05 | Why? |
| United States | 7 | 2021 | 46150 | 0.05 | Why? |
| Femoral Vein | 1 | 2020 | 43 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Louisiana | 1 | 2021 | 353 | 0.05 | Why? |
| Saphenous Vein | 1 | 2020 | 67 | 0.05 | Why? |
| Arizona | 1 | 2021 | 416 | 0.05 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.05 | Why? |
| Biopsy | 2 | 2019 | 2811 | 0.05 | Why? |
| Analgesics, Non-Narcotic | 1 | 2020 | 164 | 0.05 | Why? |
| Thrombomodulin | 1 | 2019 | 121 | 0.05 | Why? |
| Hemorrhage | 2 | 2021 | 3013 | 0.05 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
| Double-Blind Method | 2 | 2020 | 5988 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Femoral Artery | 1 | 2020 | 213 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2020 | 696 | 0.04 | Why? |
| Stakeholder Participation | 1 | 2021 | 481 | 0.04 | Why? |
| Michigan | 1 | 2021 | 988 | 0.04 | Why? |
| Punctures | 1 | 2017 | 89 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2020 | 801 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Hospitals, Community | 1 | 2021 | 475 | 0.04 | Why? |
| Pleural Diseases | 1 | 2017 | 68 | 0.04 | Why? |
| Aged | 10 | 2021 | 215776 | 0.04 | Why? |
| Organizational Policy | 1 | 2021 | 694 | 0.04 | Why? |
| Washington | 1 | 2021 | 1722 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Infusions, Intravenous | 1 | 2019 | 1224 | 0.04 | Why? |
| Critical Care Nursing | 1 | 2021 | 469 | 0.04 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.03 | Why? |
| California | 1 | 2021 | 2047 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Equipment Reuse | 1 | 2021 | 985 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2021 | 1300 | 0.03 | Why? |
| New York | 1 | 2021 | 2488 | 0.03 | Why? |
| Radiation Dosage | 1 | 2018 | 585 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2017 | 657 | 0.03 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.03 | Why? |
| Latin America | 1 | 2018 | 1721 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Oximetry | 1 | 2017 | 658 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2021 | 10649 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Ferritins | 1 | 2019 | 2055 | 0.03 | Why? |
| Radiography | 1 | 2018 | 1576 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Qualitative Research | 1 | 2021 | 4337 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Leadership | 1 | 2021 | 2241 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Nurses | 1 | 2021 | 2285 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2018 | 3088 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Japan | 1 | 2018 | 6653 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.02 | Why? |
| Elective Surgical Procedures | 1 | 2021 | 5338 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2019 | 7972 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Internship and Residency | 1 | 2021 | 4987 | 0.01 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
Duggal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(162)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(704)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_